Is Neuren Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Neuren Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $2.02, you would have made a profit of $11.54 per share or 571.29%
Yes, the average daily trading liquidity for Neuren Pharmaceuticals is $439 493 thousand. You should therefore be able to get in and out of your positions relatively fast.
Neuren Pharmaceuticals has no real debt, which is good in periods of high inflation. Neuren Pharmaceuticals has a very good net profit margin of 67.73% and should have very high tolerances against inflation.
We have calculated the inflation risk for Neuren Pharmaceuticals to be low [0.3 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.